AcelRx Pharmaceuticals, Inc.
(NASDAQ : ACRX)

( )
ACRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-1.32%18.762.0%$166.39m
ICPTIntercept Pharmaceuticals, Inc.
1.82%115.1518.6%$161.00m
JAZZJazz Pharmaceuticals Plc
1.84%136.032.3%$110.58m
GWPHGW Pharmaceuticals PLC Sponsored ADR
3.29%176.006.3%$94.31m
SAGESAGE Therapeutics, Inc.
3.62%157.988.8%$90.34m
HZNPHorizon Pharma plc
0.11%27.917.3%$86.93m
PRGOPerrigo Co. Plc
0.39%48.546.8%$68.17m
ICLRICON Plc
0.06%136.754.1%$58.96m
MNKMallinckrodt Plc
0.59%23.8021.0%$55.65m
UTHRUnited Therapeutics Corporation
1.44%122.9914.3%$55.20m
PTLAPortola Pharmaceuticals, Inc.
2.13%33.637.6%$45.58m
AERIAerie Pharmaceuticals, Inc.
7.39%49.256.9%$41.81m
MYOKMyoKardia, Inc.
2.42%55.822.4%$37.75m
ENDPEndo International Plc
0.34%8.768.9%$37.73m
MDCOMedicines Company
3.59%28.0221.8%$30.85m

Company Profile

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.